TABLES SUMMARIZING THE HISTORY OF THEINDIVIDUAL APPROVAL PROCEDURES AT ISSUE IN THIS DISPUTE

The Panel has prepared a series of tables summarizing relevant aspects of the history of the individual approval procedures at issue in this dispute The tables were prepared on the basis of information provided by the Parties, and in particular the detailed chronologies of individual approval procedures submitted by the European Communities

Since the Panel's findings tend to focus on specific stages of individual approval procedures, it seemed useful to provide some background information on developments and activities at other procedural stages Consistent with their limited purpose, the Panel's tables do not reflect any and all activities of member State authorities, EC authorities or applicants of which the Panel has been made aware. It should also be noted that the information provided in the tables is more detailed for those stages and activities which the Panel has focused on for the purposes of its analysis, and less detailed for other stages and activities.

In preparing the tables, the Panel has found it useful to distinguish the following procedural stages, which also reflect the main stages of the approval procedures set out in the relevant EC approval legislation for biotech products (Directives 90/220 and 2001/18 as well as Regulation 258/97):

(a) Consideration of application at member State level (“Member State Level”)

(b) Consideration of application at Community level (“Community Level”)